AU2001282088A1 - Immunosuppressive, antiinflammatory and analgetic compounds - Google Patents

Immunosuppressive, antiinflammatory and analgetic compounds

Info

Publication number
AU2001282088A1
AU2001282088A1 AU2001282088A AU8208801A AU2001282088A1 AU 2001282088 A1 AU2001282088 A1 AU 2001282088A1 AU 2001282088 A AU2001282088 A AU 2001282088A AU 8208801 A AU8208801 A AU 8208801A AU 2001282088 A1 AU2001282088 A1 AU 2001282088A1
Authority
AU
Australia
Prior art keywords
antiinflammatory
immunosuppressive
analgetic
compounds
analgetic compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001282088A
Inventor
Brigitte Kopp
Dan Navolan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001282088A1 publication Critical patent/AU2001282088A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU2001282088A 2000-08-17 2001-08-11 Immunosuppressive, antiinflammatory and analgetic compounds Abandoned AU2001282088A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00117675 2000-08-17
EP00117675 2000-08-17
PCT/EP2001/009311 WO2002014343A1 (en) 2000-08-17 2001-08-11 Bufadienolide derivatives and use as immunosuppressive, antiinflammatory and analgesic agents

Publications (1)

Publication Number Publication Date
AU2001282088A1 true AU2001282088A1 (en) 2002-02-25

Family

ID=8169552

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001282088A Abandoned AU2001282088A1 (en) 2000-08-17 2001-08-11 Immunosuppressive, antiinflammatory and analgetic compounds

Country Status (2)

Country Link
AU (1) AU2001282088A1 (en)
WO (1) WO2002014343A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0706377A2 (en) * 2006-01-09 2011-03-22 Btg Int Ltd hypoxia-inducible factor -1 modulators and related uses
CN101374571B (en) * 2006-01-31 2013-07-17 托莱多大学 Na/K-ATPase ligand
US8283441B2 (en) 2006-10-31 2012-10-09 University Of Toledo Na+K+-ATPase-specific peptide inhibitors/activators of SRC and SRC family kinases
CN101177445B (en) * 2006-11-08 2012-07-04 山东绿叶制药有限公司 Novel bufadienolide compound as well as preparation method and uses thereof
WO2009033505A1 (en) * 2007-09-14 2009-03-19 Unibioscreen S.A. Hellebrin derivatives
US8361973B2 (en) * 2008-08-07 2013-01-29 Centrose, Llc Glycoside compounds and pharmaceutical compositions thereof
WO2010102673A1 (en) * 2009-03-13 2010-09-16 Unibioscreen S.A. Hellebrin and hellebrigenin derivatives
BRPI0901758A2 (en) * 2009-05-28 2011-01-25 Cristalia Prod Quimicos Farm use of telokinobufagin as an analgesic in the treatment of acute and chronic pain; pharmaceutical composition containing telokinobufagin and its use
WO2011034772A1 (en) 2009-09-16 2011-03-24 The University Of Toledo Na/k-atpase ligands, ouabain antagonists, assays and uses thereof
CN102101879B (en) * 2009-12-16 2013-01-09 中国科学院大连化学物理研究所 Arenobufagin space isomer compound and preparation and application thereof
WO2011088210A1 (en) 2010-01-13 2011-07-21 The University Of Toledo Materials and methods related to sodium/potassium adenosine triphosphatase and src
EP2523966B1 (en) 2010-01-15 2017-10-04 Suzhou Neupharma Co., Ltd Certain chemical entities, compositions, and methods
ES2574205T3 (en) * 2010-04-27 2016-06-15 Pharma Mar S.A. Unsaturated anticancer steroid lactones in position 7 (8)
US9493503B2 (en) 2011-02-02 2016-11-15 Neupharma, Inc. Certain chemical entities, compositions, and methods
US9694019B2 (en) 2011-09-13 2017-07-04 Brigham Young University Compositions and methods for treating bone diseases and broken bones
WO2013165924A1 (en) 2012-04-29 2013-11-07 Neupharma, Inc. Certain chemical entities, compositions, and methods
CA2873283C (en) * 2012-05-09 2021-05-04 The Hong Kong University Of Science And Technology Method and compounds for inhibiting the mcm complex and their application in cancer treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1165593B (en) * 1961-03-04 1964-03-19 Merck Ag E Process for the production of Schiff bases from cardenolides or their 3-glycosides or 3-esters
US4175078A (en) * 1976-10-22 1979-11-20 Kharkovsky Naucho-Issledovatelsky Khimfo-Farmatsevtiches-Ky Institut Cardenolide and bufadienolide derivatives of ajmaline and process for producing same
JPH05112596A (en) * 1991-10-20 1993-05-07 Reisa Cho Medicine containing bufalin and bufadienolide as effective components
JP2515074B2 (en) * 1992-01-27 1996-07-10 学校法人昭和大学 Bufagenolide type differentiation inducer

Also Published As

Publication number Publication date
WO2002014343A1 (en) 2002-02-21
WO2002014343A8 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
AU2001282890A1 (en) Immunosensor
AU2001262847A1 (en) Language-understanding
AU2001230026A1 (en) 2,4-diaminothiazole derivatives
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2001282088A1 (en) Immunosuppressive, antiinflammatory and analgetic compounds
AU2001258349A1 (en) Bisacylguanidine
AU2001279754A1 (en) Indoloquinazolinones
AU2002211794A1 (en) Audio on location
AU2001296907A1 (en) New cellular architecture
AU2001258563A1 (en) Chromatic-dispersion compensator
AU2001258924A1 (en) Microsatellite-aflp
AU6594401A (en) 6-heterocyclyl-3-oxo-3,4-dihydro-quinoxalines
AU2002214083A1 (en) Secure keyboard
AU2001282453A1 (en) Multi-server authentication
AU2001281921A1 (en) Bdellosomes
AU2002218400A1 (en) 3-substituted 2,7-naphthyridin-1-yl derivatives
AU2001246864A1 (en) Hypotensors
AU2001266689A1 (en) 4-benzyl-2-hydroxy-1,4-oxazin-3-one and polymorphic forms thereof
AU2001282644A1 (en) Case
AUPQ673400A0 (en) Keypad
AU2001260192A1 (en) Glycinamides
AU2001262711A1 (en) Cytoprotectors